Wockhardt Limited (WOCKPHARMA) - Net Assets

Latest as of March 2025: Rs46.57 Billion INR ≈ $503.64 Million USD

Based on the latest financial reports, Wockhardt Limited (WOCKPHARMA) has net assets worth Rs46.57 Billion INR (≈ $503.64 Million USD) as of March 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs81.35 Billion ≈ $879.77 Million USD) and total liabilities (Rs34.78 Billion ≈ $376.13 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Wockhardt Limited liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs46.57 Billion
% of Total Assets	57.25%
Annual Growth Rate	10.64%
5-Year Change	23.85%
10-Year Change	7.24%
Growth Volatility	24.87

Wockhardt Limited - Net Assets Trend (2005–2025)

This chart illustrates how Wockhardt Limited's net assets have evolved over time, based on quarterly financial data. Also explore Wockhardt Limited total assets for the complete picture of this company's asset base.

Annual Net Assets for Wockhardt Limited (2005–2025)

The table below shows the annual net assets of Wockhardt Limited from 2005 to 2025. For live valuation and market cap data, see WOCKPHARMA stock market capitalisation.

Year	Net Assets	Change
2025-03-31	Rs46.57 Billion ≈ $503.64 Million	+27.17%
2024-03-31	Rs36.62 Billion ≈ $396.03 Million	0.00%
2023-03-31	Rs36.62 Billion ≈ $396.03 Million	-12.85%
2022-03-31	Rs42.02 Billion ≈ $454.43 Million	+11.75%
2021-03-31	Rs37.60 Billion ≈ $406.66 Million	+22.99%
2020-03-31	Rs30.57 Billion ≈ $330.65 Million	+1.76%
2019-03-31	Rs30.05 Billion ≈ $324.94 Million	-6.04%
2018-03-31	Rs31.98 Billion ≈ $345.84 Million	-14.00%
2017-03-31	Rs37.19 Billion ≈ $402.16 Million	-14.37%
2016-03-31	Rs43.43 Billion ≈ $469.66 Million	+12.53%
2015-03-31	Rs38.59 Billion ≈ $417.37 Million	+3.81%
2014-03-31	Rs37.18 Billion ≈ $402.05 Million	+37.48%
2013-03-31	Rs27.04 Billion ≈ $292.45 Million	+83.83%
2012-03-31	Rs14.71 Billion ≈ $159.09 Million	+30.59%
2011-03-31	Rs11.26 Billion ≈ $121.82 Million	+34.86%
2010-03-31	Rs8.35 Billion ≈ $90.33 Million	-17.93%
2009-03-31	Rs10.18 Billion ≈ $110.06 Million	-20.09%
2008-03-31	Rs12.74 Billion ≈ $137.73 Million	+19.44%
2007-03-31	Rs10.66 Billion ≈ $115.32 Million	+30.66%
2006-03-31	Rs8.16 Billion ≈ $88.26 Million	+32.36%
2005-03-31	Rs6.17 Billion ≈ $66.68 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Wockhardt Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 188000000000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (March 2025)

Component	Amount	Percentage
Retained Earnings	Rs1.88 Billion	4.32%
Common Stock	Rs810.00 Million	1.86%
Other Comprehensive Income	Rs18.44 Billion	42.36%
Other Components	Rs22.40 Billion	51.46%
Total Equity	Rs43.53 Billion	100.00%

Wockhardt Limited Competitors by Market Cap

The table below lists competitors of Wockhardt Limited ranked by their market capitalization.

Company	Market Cap
OPERAD.D.SIT.MEX.A1 -01 F:98Y	$2.45 Billion
CJ Cheiljedang KO:097950	$2.46 Billion
China Marine Information Electronics Co Ltd SHG:600764	$2.46 Billion
Beijing Hualian Hypermarket Co Ltd SHG:600361	$2.46 Billion
Pearl Abyss Corp KQ:263750	$2.45 Billion
Treasury Wine Estates Ltd AU:TWE	$2.45 Billion
Highwoods Properties Inc NYSE:HIW	$2.45 Billion
Inter & Co. Inc. Class A Common Shares NASDAQ:INTR	$2.45 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Wockhardt Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 33,590,000,000 to 43,530,000,000, a change of 9,940,000,000 (29.6%).
Net loss of 470,000,000 reduced equity.
Share repurchases of 9,830,000,000 reduced equity.
New share issuances of 9,830,000,000 increased equity.
Other comprehensive income increased equity by 630,000,000.
Other factors increased equity by 9,780,000,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Rs-470.00 Million	-1.08%
Share Repurchases	Rs9.83 Billion	-22.58%
Share Issuances	Rs9.83 Billion	+22.58%
Other Comprehensive Income	Rs630.00 Million	+1.45%
Other Changes	Rs9.78 Billion	+22.47%
Total Change	Rs-	29.59%

Book Value vs Market Value Analysis

This analysis compares Wockhardt Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 5.03x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 26.84x to 5.03x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2005-03-31	Rs51.99	Rs1395.60	x
2006-03-31	Rs68.82	Rs1395.60	x
2007-03-31	Rs89.78	Rs1395.60	x
2008-03-31	Rs107.24	Rs1395.60	x
2009-03-31	Rs85.70	Rs1395.60	x
2010-03-31	Rs70.34	Rs1395.60	x
2011-03-31	Rs94.85	Rs1395.60	x
2012-03-31	Rs123.26	Rs1395.60	x
2013-03-31	Rs243.15	Rs1395.60	x
2014-03-31	Rs322.54	Rs1395.60	x
2015-03-31	Rs333.95	Rs1395.60	x
2016-03-31	Rs320.95	Rs1395.60	x
2017-03-31	Rs301.87	Rs1395.60	x
2018-03-31	Rs257.94	Rs1395.60	x
2019-03-31	Rs241.71	Rs1395.60	x
2020-03-31	Rs241.30	Rs1395.60	x
2021-03-31	Rs281.06	Rs1395.60	x
2022-03-31	Rs319.26	Rs1395.60	x
2023-03-31	Rs232.81	Rs1395.60	x
2024-03-31	Rs232.86	Rs1395.60	x
2025-03-31	Rs277.42	Rs1395.60	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Wockhardt Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -1.08%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -1.55%
• Asset Turnover: 0.37x
• Equity Multiplier: 1.87x
Recent ROE (-1.08%) is below the historical average (3.84%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2005	34.63%	17.23%	0.65x	3.11x	Rs1.52 Billion
2006	40.67%	23.49%	0.66x	2.63x	Rs2.50 Billion
2007	32.55%	20.07%	0.47x	3.48x	Rs2.40 Billion
2008	30.29%	14.54%	0.51x	4.05x	Rs2.58 Billion
2009	-13.64%	-3.87%	0.53x	6.61x	Rs-2.41 Billion
2010	-119.80%	-22.23%	0.79x	6.85x	Rs-10.84 Billion
2011	8.04%	2.41%	0.64x	5.23x	Rs-221.24 Million
2012	23.30%	7.43%	0.74x	4.25x	Rs1.96 Billion
2013	58.39%	28.06%	0.93x	2.23x	Rs13.08 Billion
2014	23.47%	17.40%	0.73x	1.85x	Rs4.83 Billion
2015	10.90%	9.04%	0.65x	1.87x	Rs333.75 Million
2016	6.47%	5.63%	0.56x	2.05x	Rs-1.37 Billion
2017	-5.87%	-4.93%	0.44x	2.69x	Rs-5.29 Billion
2018	-21.33%	-15.50%	0.48x	2.86x	Rs-8.94 Billion
2019	-7.27%	-5.46%	0.46x	2.93x	Rs-4.62 Billion
2020	-2.59%	-2.43%	0.35x	3.06x	Rs-3.36 Billion
2021	20.32%	25.33%	0.35x	2.30x	Rs3.48 Billion
2022	-6.34%	-7.55%	0.39x	2.14x	Rs-6.29 Billion
2023	-16.67%	-21.04%	0.35x	2.29x	Rs-8.94 Billion
2024	-13.78%	-16.36%	0.37x	2.28x	Rs-7.99 Billion
2025	-1.08%	-1.55%	0.37x	1.87x	Rs-4.82 Billion

Industry Comparison

This section compares Wockhardt Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $23,713,303,062
Average return on equity (ROE) among peers: 8.81%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Wockhardt Limited (WOCKPHARMA)	Rs46.57 Billion	34.63%	0.75x	$2.45 Billion
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS)	$988.60 Million	6.59%	1.36x	$27.93 Million
Aarti Drugs Limited (AARTIDRUGS)	$6.52 Billion	21.67%	1.42x	$371.43 Million
Aarti Pharmalabs Limited (AARTIPHARM)	$19.90 Billion	13.69%	0.46x	$725.68 Million
Abbott India Limited (ABBOTINDIA)	$36.99 Billion	32.48%	0.40x	$5.85 Billion
Ajanta Pharma Limited (AJANTPHARM)	$1.16 Billion	12.69%	1.32x	$3.81 Billion
Akums Drugs and Pharmaceutical (AKUMS)	$6.25 Billion	-40.39%	3.91x	$906.19 Million
Alkem Laboratories Limited (ALKEM)	$88.47 Billion	18.60%	0.59x	$6.98 Billion
Amrutanjan Health Care Limited (AMRUTANJAN)	$1.46 Billion	16.82%	0.29x	$178.52 Million
Alembic Pharmaceuticals Limited (APLLTD)	$51.90 Billion	11.24%	0.50x	$1.60 Billion
Aurobindo Pharma Limited (AUROPHARMA)	$23.50 Billion	-5.26%	1.65x	$8.73 Billion

About Wockhardt Limited

NSE:WOCKPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$2.45 Billion

Rs226.77 Billion INR

Market Cap Rank

#5536 Global

#243 in India

Share Price

Rs1395.60

Change (1 day)

+0.28%

52-Week Range

Rs1100.30 - Rs1831.10

All Time High

Rs1831.10